Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
Eriko MasudaKazuaki FukushimaYu HebisawaMasayuki TanakaAkito OhtaAkifumi ImamuraPublished in: Medicine (2023)
COVID-19-associated TMA should be considered as a differential diagnosis during the COVID-19 epidemic. Excessive inflammation and severe COVID-19 are not essential for TMA development. Early intervention using conventional TMA treatments, such as plasma exchange and corticosteroids, might be important in improving prognosis while differentiating between TTP and atypical hemolytic uremic syndrome. Antihypertensive therapy may be helpful in the treatment of COVID-19-associated TMA.
Keyphrases
- coronavirus disease
- sars cov
- respiratory syndrome coronavirus
- case report
- blood pressure
- randomized controlled trial
- oxidative stress
- hiv infected
- antiretroviral therapy
- human immunodeficiency virus
- hiv positive
- hepatitis c virus
- hiv aids
- magnetic resonance
- early onset
- magnetic resonance imaging
- computed tomography
- hypertensive patients
- replacement therapy
- smoking cessation
- hiv testing
- weight gain
- newly diagnosed